ArticleClinical rheumatology2026
Shared genetic architecture and potential comorbid mechanisms between rheumatoid arthritis and idiopathic pulmonary fibrosis.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesRheumatoid arthritis (RA) and idiopathic pulmonary fibrosis (IPF) commonly coexist, notably in RA-associated interstitial lung disease. Despite clinical overlap, their shared genetic underpinnings remain poorly understood.
methodUsing large-scale genome-wide association study (GWAS) data from European populations, we assessed genetic correlations between RA and IPF through linkage disequilibrium score regression (LDSC) and high-definition likelihood (HDL). Pleiotropic SNPs and shared loci were identified via pleiotropic analysis under the composite null hypothesis (PLACO), functional mapping and annotation of genetic associations (FUMA), and Bayesian colocalization. Multi-marker Analysis of GenoMic Annotation (MAGMA) pinpointed pleiotropic genes, followed by functional enrichment, transcription factor, cell-type specificity, and immune cell colocalization analyses.
resultsSignificant positive genetic correlations were identified (LDSC: rg = 0.321, P = 0.002; HDL: rg = 0.67, P = 5.01 × 10
conclusionsOur findings reveal significant genetic correlations and potential shared genetic mechanisms between RA and IPF, identifying pleiotropic genes and loci involved in immune pathways. This provides foundational genetic insights for exploring pathogenesis and targeted therapies in RA-IPF comorbidity. Key Points • The genetic relationship between rheumatoid arthritis (RA) and idiopathic pulmonary fibrosis (IPF) remains poorly understood despite their frequent clinical coexistence. • We applied genome-wide methods, including LDSC, HDL, PLACO, and MAGMA, to explore shared genetic architecture and immune mechanisms. • Our findings highlight potential common immune-regulatory pathways underlying RA-IPF comorbidity, offering new insights into pathogenesis and therapy development.
Indexed as
Identifiers
41174273What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.